Form 4: Outset Medical Executive Sells Shares to Cover Tax Obligations
SEC Form 4
An Outset Medical executive, Marc Nash, sold 1,375 shares of common stock to cover tax obligations related to vesting of restricted stock units.
Summary
- Marc Nash, SVP of Operations and R&D at Outset Medical, sold 1,375 shares of common stock on November 15, 2024.
- The sale was executed at a price of $0.8 per share.
- This transaction was to cover tax withholding obligations associated with the vesting of 3,584 shares of common stock underlying restricted stock units (RSUs).
- The RSUs were granted on multiple dates: March 8, 2021, March 15, 2021, March 15, 2022, March 15, 2023, and July 24, 2023.
- The sale was a 'sell to cover' transaction and not a discretionary trade by the reporting person.
- Following the transaction, Marc Nash beneficially owns 238,022 shares of Outset Medical common stock.
Sentiment
Score: 5
Explanation: This is a neutral event, a routine transaction for tax purposes, and does not indicate any positive or negative sentiment about the company's performance.
Management Comments
- The sale was made to satisfy tax withholding obligations through a 'sell to cover' transaction and does not represent a discretionary trade by the reporting person.
Industry Context
This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when RSUs vest.
Comparison to Industry Standards
- The 'sell to cover' transaction is a standard practice across many publicly traded companies.
- Executives often use this method to manage their tax liabilities associated with equity compensation.
- The number of shares sold is relatively small compared to the total shares owned by the executive, which is typical for these types of transactions.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 2021-03-08 | Date of one of the RSU grants. |
| 2021-03-15 | Date of one of the RSU grants. |
| 2022-03-15 | Date of one of the RSU grants. |
| 2023-03-15 | Date of one of the RSU grants. |
| 2023-07-24 | Date of one of the RSU grants. |
| 2024-11-15 | Date of the stock sale transaction. |
| 2024-11-18 | Date the Form 4 was signed. |
Keywords
Outset Medical, stock sale, insider trading, Form 4, tax withholding, restricted stock units, RSU, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.